Accessibility information | Access Keys

µBead size selection is a clinical decision.
Data from current customers shows that 300-500µm beads are the most commonly used.
Smaller beads (100-300µm) may be used to ensure the total drug dose is delivered.
Larger beads (500-700µm or 700-900µm) to ensure an embolic end point is achieved.
The products may not be available for sale, may not be registered, approved or cleared for use as claimed, in all countries where Biocompatibles is represented.
© 2010 Biocompatibles UK Ltd - All rights reserved - Site map - Terms & conditions - Accessiblity - Help - Glossary